A Phase III Randomised Open-Label Study Of Extended Adjuvant Therapy With Camizestrant Vs Standard Endocrine Therapy (Et) In Patients With Er+/Her2 Early Breast Cancer (Bc) And An Intermediate Or High Risk Of Recurrence (Cambria-1)
Camizestrant
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: A Phase III Randomised Open-Label Study Of Extended Adjuvant Therapy With Camizestrant Vs Standard Endocrine Therapy (Et) In Patients With Er+/Her2 Early Breast Cancer (Bc) And An Intermediate Or High Risk Of Recurrence (Cambria-1) ### Output: Camizestrant